Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Horm Res Paediatr. 2011;76 Suppl 1:47-51. doi: 10.1159/000329163. Epub 2011 Jul 21.

Screening and treatment of dyslipidemias in children and adolescents.

Author information

  • Department of Pediatrics, University of Colorado, Denver School of Medicine, Aurora, CO 80045, USA. daniels.stephen@tchden.org

Abstract

BACKGROUND/AIMS:

Cardiovascular disease is the most prominent cause of mortality worldwide. A key risk factor for atherosclerotic cardiovascular disease is the presence of dyslipidemia. Clinical approaches to evaluation and treatment of dyslipidemia in children and adolescents are presented.

METHODS:

A review of published guidelines and presentation of illustrative cases.

RESULTS:

Dyslipidemia is an important risk factor in early-stage atherosclerosis. Children and adolescents at high risk for dyslipidemia can be identified using a positive family history or the presence of other risk factors as a trigger. Once high-risk individuals are identified, primary treatment is lifestyle modification. In cases where low-density lipoprotein-cholesterol is high, pharmacologic intervention may be needed.

CONCLUSIONS:

Screening of appropriate children and adolescents for dyslipidemia and treating those at high risk are important for the long-term prevention of cardiovascular disease.

Copyright © 2011 S. Karger AG, Basel.

PMID:
21778749
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Write to the Help Desk